The nuclear factor (NF)-KB transcription factor system is composed of at least four inducible nucleoprotein adducts termed p50, p55 (NF-KB p50), p75 (NF-KB p65), and p85 (c-Rel). These proteins are expressed in the nuclei ofactivated T cells in a distinctly biphasic fashion, with p55 and p75 induction occurring within minutes whereas the induction of p50 and p85 occurs after several hours. In contrast, p50 and p55 are constitutively expressed in the nuclei of U937 and THP-1 monocytic cells. However, cellular activation is required for the nuclear expression of p75 in these cells. Additionally, activation of monocytic cells does not result in a significant induction of p85. Tumor necrosis factor a induces the nuclear expression of p55 and p75 in these monocytic cells within 20 min. presumably reflecting the liberation of these proteins from IxB. In contrast, phorbol myristate acetate (PMA) induces the expression of these proteins with delayed kinetics, raising the possibility that PMA is incapable of mediating the efficient release of p55 and p75 from IUB in these cells. These findings highlight important differences in the regulation ofthese proteins in monocytic cells versus T cells and suggest that the induced expression of NF-KB p65 in monocytes may play a central role in the activation of HIV-l gene expression. (J. Clin. Invest. 1992. 90:121-129.) 
Introduction
CD4+ T lymphocytes and CD4+ cells ofthe phagocytic mononuclear cell system, including circulating peripheral blood monocytes and extravascular tissue macrophages, appear to represent the major cellular targets for infection by the type 1 HIV (1) (2) (3) (4) (5) . In sharp contrast to its lethal effects on T cells, HIV-l exerts only minimal cytopathic effects on infected monocytic cells. Thus, these cells may serve as an important viral reservoir and as a cellular conduit for the spread of HIV-l to other tissues of the body, including the central nervous system (3, 5, 6) . Various host transcription factors, notably members ofthe family ofRel-related KB enhancer-binding proteins, have been shown to bind to and functionally activate the long termi-nal repeat (LTR)' ofHIV-1 (7) (8) (9) (10) . These host factors may thus play a critical role in the initial activation of HIV-l gene expression that signals the transition from a latent, or persistent, form ofinfection to a high level ofviral replication. The induction of these KB-specific DNA-binding proteins normally serves to regulate the expression of an array of cellular genes, including the K immunoglobulin light chain (11, 12) , the a subunit of the IL-2 receptor (IL-2Ra) (8, (13) (14) (15) , IL-2 (16), granulocyte-macrophage colony-stimulating factor (17, 18) , and lymphotoxin (19) .
Recent ultraviolet (UV)-crosslinking studies performed with phorbol ester-activated T cells revealed the presence of four inducible proteins giving rise to KB-specific nucleoprotein adducts termed p50, p55, p75, and p85 (8, 20, 21) . The p55 adduct contains the 50-kD subunit of nuclear factor (NF)-KB (NF-KB p50) (22) (23) (24) (25) ) whereas p50 appears to correspond to a closely related gene product, perhaps a proteolytic fragment or alternatively spliced form of NF-KB p50 (20, 21) . The p75 adduct contains the previously described 65-kD subunit ofNF-KB (NF-KB p65) (25) (26) (27) (28) whereas p85 is composed of the c-rel proto-oncogene product (21) . It is now clear that both the NF-KB p65 and c-Rel proteins can engage the KB enhancer element in the absence ofthe smaller KB-specific DNA-binding proteins (21, 26, 28) . All four ofthese proteins have been found to share homology with the v-rel oncogene from the avian reticuloendotheliosis virus, REV T (21, 26, (28) (29) (30) . Of note, v-rel functions as a repressor of KB enhancer-directed transcription in mature human T cells (21) . In phorbol ester-activated Jurkat T cells, nuclear expression of these four proteins occurs in a distinctly biphasic manner with p55 (NF-KB p50) and p75 (NF-KB p65) appearing in the nucleus within 20 min of phorbol ester activation whereas p50 and p85 (c-Rel) are detectable only after > 4 h of activation (20) . All of these proteins are detectable as preformed factors in T cells and are sequestered in the cytoplasm by an inhibitor likely identical to one or more ofthe forms ofIKB (20, 21, 24, 25, 31, 32) . However, in contrast to the early expression of p55 (NF-KB p50) and p75 (NF-KB p65) in activated T cells, the late nuclear expression of p50 and p85 (c-Rel) also involves a significant component ofde novo synthesis of these proteins (20) .
In this report, we compare and contrast the regulation of this Rel-related family ofKB enhancer-binding proteins in relatively mature (THP-1) and immature (U937) human monocytic cell lines with that previously reported in human Jurkat T cells. We have detected a distinctly different pattern of expression ofthese proteins in these monocytic cells and now demon-strate that NF-KB p50 is constitutively expressed in the nuclei of both U937 and THP-l cells. In contrast, nuclear expression of NF-KB p65 requires cellular activation by such agents as tumor necrosis factor a (TNFa) or phorbol myristate acetate (PMA). Functionally, this induction in the nuclear expression of NF-KB p65 in both U937 and THP-l cells is correlated with the transcriptional activation ofthe HIV-1 LTR. Furthermore, in contrast to the delayed, but marked, induction ofp85 (c-Rel) in human Jurkat T cells, little increase in the nuclear expression of this proto-oncogene product occurs in activated U937 or THP-1 monocytic cells. Finally, we demonstrate that the kinetics of TNFa and PMA induction of these various KB enhancer-binding proteins are very different in these monocytic cells compared with human Jurkat T cells. Specifically, we have found that TNFa stimulates the rapid nuclear translocation (. 20 min) of NF-KB p50 and NF-KB p65 in both of these human monocytic cell lines (U937 and THP-1). In contrast, PMA promotes only a delayed nuclear expression of these factors in both U937 and THP-1 monocytic cells, suggesting that this tumor promoter may fail to mobilize these preformed cytoplasmic factors for transport to the nucleus in these cells, but may act by inducing their de novo synthesis.
Methods
Cell lines and nuclear extract preparation. The human promonocytic U937 cell line (33) and the relatively mature human monocytic THP-l cell line (34) were obtained from the American Type Culture Collection (ATCC, Rockville, MD) and were cultured in RPMI 1640 medium supplemented with 7.5% FCS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 ug/ml streptomycin. U937 and THP-1 cells were routinely grown to a density of 4-8 X 105 and 3-6 X 105 cells/ml, respectively. Human Jurkat T cells were grown under similar conditions as the U937 cells. Based on several parameters, the U937 cells correspond to relatively immature monocytic cells whereas the THP-1 cells represent a more mature population ofcells (33) (34) (35) . THP-I cells grow less rapidly than U937 cells, with doubling times of 37 and 17 h, respectively. Compared with U937 cells, the THP-I cells express significantly higher levels ofselect membrane antigens consistent with a more mature, or differentiated, cellular phenotype. Specifically, indirect immunofluorescence staining and analysis on a fluorescence-activated cell sorter has revealed the following percent positive cells for the THP-1 and U937 cell lines, respectively: OKMl (CD 1 lb) 75% and 38%, LeuM3 (CD 14) 20% and 2%, and HLA-DR 62% and 8%.
Cell populations were stimulated with either phorbol 12-myristate 13-acetate (PMA) at a final concentration of 50 ng/ml or TNFa (Genzyme Corp., Boston, MA), at final concentrations generally ranging between 10 and 100 U/ml. Nuclear extracts were prepared at various times after stimulation as previously described (20, 36, 37) , using aliquots of 3-10 X I07 cells, with the following modifications:
(a) All steps in the nuclear extraction procedure were performed at 4C.
(b) The hypotonic lysis buffer (buffer I) contained the following (mM): 10 Hepes (pH 7.9), 1.5 MgCl2, 10 KCl, 0.1 EGTA, and 0.5 dithiothreitol. 0.5 mM phenylmethylsulfonyl fluoride, 0.5 mg/ml antipain, 0.5 mg/ml aprotinin, 0.5 mg/ml leupeptin, 0.05 mg/ml pepstatin, and 0.5 mg/ml soybean trypsin inhibitor were also added to both the hypotonic lysis buffer and all subsequent buffers used during the preparation of the nuclear extracts.
(c) The cell pellet wash in buffer I was omitted, and the cell pellet was resuspended in -5 vol of buffer I before homogenization with a loose-fitting Dounce homogenizer (Fisher Scientific Co., Pittsburgh, PA). Nuclei were collected by centrifugation at 3,000 rpm for 5 min in an Eppendorf microfuge (Brinkmann Instruments Inc., Westbury, NY).
(d) The nuclear pellet wash in buffer I after Dounce homogenization was omitted, and the nuclear pellet obtained after cell lysis was resuspended in 2.5 vol ofbuffer 11 (20 mM Gel retardation and UV-crosslinking analysis. Double-stranded photoreactive 32P-radiolabeled oligonucleotide probes containing the KB enhancer element were prepared as previously described (15, 20, 38) . Briefly, a 27-nucleotide single strand spanning the plus strand KB enhancer element of the IL-2Ra gene (5' CAACGGCAGGG-GAATCTCCCTCTCCTT 3') was annealed to a complementary I0-bp primer, followed by primer extension with the Klenow fragment of DNA polymerase I in the presence of 5'-bromo-2'-deoxyuridine 5' triphosphate (BrdU) and [ac-32Pldeoxynucleoside triphosphates. Gel retardation assays were performed as previously described using this photoreactive probe, and DNA-protein complexes were separated from the free DNA probe by electrophoresis through low ionic strength 5% polyacrylamide gels (8) . UV-crosslinking was performed in solution by irradiating the respective nuclear extract and 32P-BrdU KB oligonucleotide probe with a 300-nM UV light source (7000 mW/cm illuminator, Fotodyne Inc., New Berlin, WI) for 20 min and then analyzing the UV-crosslinked adducts directly on discontinuous SDS 7.5% polyacrylamide gels electrophoresed under reducing conditions. Transient DNA transfection and chloramphenicol acetyl transferase assays. U937 and THP-l cells cultured as described above were transiently transfected with previously described reporter plasmids containing either the HIV-l LTR (position -633 to +80 relative to the start of transcription) linked to the bacterial chloramphenicol acetyl transferase (CAT) gene (HIV-LTR CAT) or an identical construct containing a 3-bp substitution mutation in both KB-enhancer elements (GGG --CTC) (AKB HIV-LTR CAT) (39) . These plasmids were introduced using a standard DEAE-dextran transfection procedure (40) modified by the omission of exposure to chloroquine. Briefly, 5 x 106 U937 cells or 7.5 X 106 THP-l cells were transfected with 1-3 ,ug of plasmid DNA, and selected cultures were stimulated with either 50 ng/ml PMA or 100 U/ml TNFa after 18-24 h ofculture. CAT activity was assayed 36-48 h after transfection (41) . Results are shown as the mean fold increase of CAT activity relative to the response obtained with media alone. All values were normalized for total protein recovery as determined by the Bradford colorimetric assay (42) . Percent conversion of chloramphenicol to 3H-acetyl chloramphenicol was calculated using a value of 100% for the activity obtained with the addition of0.5 U of purified CAT (Boehringer Mannheim Biochemicals, Indianapolis, IN).
Results
The pattern ofexpression ofthe family ofKB enhancer-binding proteins in the U937 and THP-1 monocytic cell lines was first investigated using gel retardation assays. Nuclear extracts prepared from unstimulated promonocytic U937 cells revealed the constitutive expression of one or more KB enhancer-binding proteins mediating the formation of a relatively rapidly migrating nucleoprotein complex designated B2 ( Fig. 1 A, lane 1). The addition of a 100-fold molar excess of unlabeled wildtype competitor (KB-WT), but not unlabeled mutant competitor lacking the KB enhancer sequences (AKB), blocked the formation of this B2 complex thus confirming the sequence-specific nature of this DNA-protein interaction ( Fig The phenotypically more mature THP-l cells also were found to constitutively express KB enhancer-binding proteins mediating formation of the B2 complex, as well as a low level expression of the B I complex (Fig. 1 B, lanes 1-3) . TNFa activation of these THP-1 cells markedly augmented the amount of this specific B1 complex (Fig. 1 B, lanes 4-6) . In contrast, and in agreement with earlier studies (7, (13) (14) (15) 20) , no KB enhancer-binding proteins were constitutively expressed in uninduced Jurkat T cells (Fig. 1 C, lanes 1-3) . However, PMA activation of these Jurkat cells for only 20 min induced the nuclear expression of the KB enhancer-binding proteins mediating formation of both the B2 and B 1 complexes ( Fig. 1 C,  lane 4) . Similarly, TNFa activation of Jurkat T cells induced both B2 and B1 complex formation (data not shown).
In addition to its duplicated KB enhancer elements, the HIV-1 LTR contains a triplet of adjacent Sp 1 sites that are importantly required for the normal function ofthis transcription unit (43) . The nuclear extracts from these monocytic and T cell lines were also analyzed for Sp I binding activity, which is normally expressed in a constitutive manner. The nuclear extracts isolated from unstimulated or TNFa-activated U937 cells contained virtually indistinguishable amounts ofSp I (Fig.  1 D, lanes 1-3) . Additionally, whereas the nuclear extracts from uninduced Jurkat T cells contained essentially no KB-enhancer-binding proteins, the Sp 1 transcription factor was present in amounts comparable to that found in PMA-induced Jurkat cells (Fig. 1 D, lanes 5-7) as well as in uninduced and induced U937 cells. Unstimulated and TNFa-activated THP-1 nuclear extracts also contained similar quantities of SpI (Fig. 1  D, lanes 9 and 10) . These results thus demonstrate a lack of induction of an independent DNA-binding protein in these unstimulated and stimulated nuclear extracts and furthermore provide an important internal control confirming the quality of the various nuclear extract preparations.
To characterize both the constitutive and inducible KB-enhancer-binding proteins expressed in the U937 and THP-1 cells, UV-crosslinking studies were performed using the same extracts employed in Fig. 1 . Unstimulated U937 cells were found to constitutively express in their nuclei proteins giving rise to both the p50 and p55 adducts (Fig. 2, lanes 1-3) . Although the protein component of p50 proved to be the major constitutively expressed KB-enhancer-binding protein in U937 cells, the p55 adduct (NF-KB p50) was consistently detected. These same lower molecular weight KB enhancer-binding proteins were also expressed in a constitutive manner in THP-1 cells (Fig. 2, lanes 7-9) . TNFa activation of both U937 and THP-1 cells, which induced B1 complex formation, not only resulted in a marked increase in p55 (NF-KB p50) expression but also in the de novo nuclear expression ofNF-KB p65, which mediates the formation of the p75 crosslinked adduct (Fig. 2,  lanes 4 and 10) . No further induction of p50 was evident in either the TNFa-activated U937 or THP-1 cells. Interestingly, UV-crosslinking analyses of uninduced THP-1 nuclear extracts did not reveal the presence ofp75 (NF-KB p65), although small amounts ofthe B I complex were evident in the gel retardation assay. This finding may be due to different sensitivities . This reaction mixture was irradiated under a 300 nM UV light source in solution, and the resultant UV-crosslinked adducts directly analyzed on discontinuous SDS 7.5% polyacrylamide gels electrophoresed under reducing conditions. Competition experiments were performed using a 100-fold molar excess of unlabeled KB-WT or AKB oligonucleotides (see Fig. 1 in the two assay systems. Earlier in situ UV-crosslinking studies (20) have shown that the B2 complex from activated Jurkat T cells contains both p50 and p55 (NF-KB p50) whereas the BI complex from these cells contains p50, p55 (NF-KB p50), p75 (NF-KB p65), and p85 (c-Rel). In sharp contrast to the marked induction of c-Rel expression in PMA-activated T cells (20) , only trace amounts of the p85 (c-Rel) crosslinked adduct were observed in either TNFa-or PMA-activated monocytic cell lines (see Figs. 2 and 6 , and data not shown).
To evaluate the functional consequences of the induced nuclear expression of NF-KB p65 in these monocytic cells, we analyzed both the basal and TNFa-or PMA-induced activity of HIV-LTR CAT reporter plasmids transfected into the U937 and THP-1 cell lines. Uninduced U937 cells constitutively expressed a low level of CAT enzyme activity, however, both TNFa and PMA induction of these cells led to marked stimulation of the HIV-l LTR (Fig. 3 A) . The more mature THP-1 cells exhibited a higher basal level of CAT activity than U937 cells (Fig. 3 B) . Similar to the findings in U937 cells, however, both TNFa and PMA also induced a 5-10-fold increase in HIV-l LTR activity in these cells (Fig. 3 B) . Activation of the HIV-1 LTR in both cell lines importantly involved protein interactions at the KB enhancer, as an HIV-LTR CAT construct containing mutant KB enhancer elements (AKB HIV-LTR CAT) exhibited markedly reduced activity in response to either TNFa or PMA (Fig. 3 A and B The dose-response relationship for the TNFa induction of the NF-KB p65-dependent BI complex formation in U937 cells was next investigated (Fig. 4) . TNFa concentrations ranging from 10 to 500 U/ml effectively induced the appearance ofthe B I complex, with a maximal response being noted at 10 U/ml. Concentrations of TNFa as low as 1 U/ml induced a small but consistent increase in B1 complex formation. This dose-response curve for TNFa falling between 1 and 10 U/ml is within the range of this cytokine seen in various pathophysiological conditions (44, 45) .
We next analyzed the kinetics of TNFa and PMA induction ofthese KB enhancer-binding proteins in U937 cells. Similar to its effects on T cells, TNFa rapidly induced B 1 complex formation in the U937 monocytic cells, with a detectable response occurring within 20 min (Fig. 5 A) . However, in sharp contrast, PMA activation required between 2 and 4 h to induce B1 complex formation in these U937 cells (Fig. 5 B) . These latter results differ markedly from the rapid kinetics of induc- tion found with PMA in human Jurkat T cells (Fig. 1 C) (20) . Similar to the response in U937 cells, in THP-1 cells TNFa induced a rapid Bl complex formation whereas PMA exhibited the same slow kinetics ofinduction (data not shown). UVcrosslinking studies demonstrated that the rapid TNFa induction of the B I complex in U937 cells correlated with the rapid induction of both p55 (NF-KB p50) and p75 (NF-KB p65) (Fig.  6 A) . Similarly, the delayed induction of B 1 by PMA in these cells also correlated with the delayed induction of p55 (NF-KB p50) and p75 (NF-KB p65) (Fig. 6 B) . In further contrast to the effects of PMA on Jurkat T cells (20) , p85 (c-Rel) was not significantly induced by either TNFa or PMA in U937 or THP-l monocytic cells (Fig. 6, A and B) .
Discussion
In this study we were incubated with a 32P-radiolabeled BrdU-substituted IL-2Ra KB oligonucleotide probe. The reaction mixtures were then irradiated with UV light in solution and analyzed on a discontinuous SDS 7.5% polyacrylamide gel (see Fig. 2 legend) . Competition experiments were performed in the presence (+) or absence (-) of a 100-fold molar excess of unlabeled wild-type IL-2Ra KB. The migration positions of p50, p55 (NF-KB p50), p75 (NF-KB p65), and p85 (c-Rel) are indicated.
9, 13, 20, [46] [47] [48] . These studies were performed with the hope of providing new information bearing on the nature of the pathogen-host interaction of HIV-1 with monocytes. Before discussing the important differences detected in the pattern of KB-enhancer-binding protein expression in these monocytic cells, it is appropriate to review the evolution of our understanding of NF-KB DNA-binding activity, which in fact corresponds to a multigene family encoding structurally related gene products. Early studies suggested that the KB enhancer, now identified in several inducible cellular and viral transcription units including the HIV-I LTR (7, 8, 11-15, 17, 18) , is engaged by a single 50-kD polypeptide termed NF-KB p50 which in turn is associated with a 65-kD non-DNA-binding subunit (p65) (24, 25, (29) (30) (31) . Both the 50-and the 65-kD subunits ofNF-KB are constitutively expressed in a broad array of cells, however, constitutive nuclear DNA-binding activity occurs in only a few cell types, notably mature B cells (11, 47, 48) . In most other cells, the preformed NF-KB p50 and NF-KB p65 polypeptides are complexed with a cytoplasmic inhibitor, termed IKB, which inhibits both the nuclear expression and DNA-binding activity ofthe complex (24, 31, 48) . This interaction with 1KB appears to be mediated through the NF-KB p65 subunit, which thus can be viewed as the cellular receptor for IKB (25) . Cellular activation by a variety of stimulants promotes the disassembly of this complex, perhaps as a consequence of phosphorylation of IKB (32) . This disassociation in turn allows the rapid translocation of the NF-KB/p65 complex to the nucleus (13, 14, 32, 46, 49, 50) . It has been proposed that this complex exists as a heterotetramer (25) , although more recent data are consistent with a heterodimeric structure (21) . Strikingly, molecular cloning of human and murine NF-KB p50 and NF-KB p65 cDNAs has revealed structural homology ofthese proteins with the v-rel oncogene and the dorsal gene of Drosophila, which functions as a maternal morphogen (26, (28) (29) (30) . Further, these studies have demonstrated that NF-KB p65 alone exhibits DNA-binding activity specific for the KB enhancer (26, 28) . More recently, we have found that the NF-KB p65 subunit contains a potent transcription activation domain near its carboxy terminus whereas NF-KB p50 appears to lack such an activity (27) .
Independent UV-crosslinking studies have revealed an even more complex array of KB enhancer-binding proteins in human T cells and HeLa epithelial cells. Specifically, four UVcrosslinked adducts (p50, p55, p75, and p85) have been identified (8, 15, 20, 21) . All of the protein components of these adducts appear structurally related to the v-rel oncogene product, based on their specific immunoreactivity with anti-v-Rel antibodies (21) . As noted above, the p85 adduct has now been shown to correspond to the 82-kD c-rel proto-oncogene product (21) , while p55 and p75 correspond to NF-KB p50 and NF-KB p65, respectively (21, (26) (27) (28) . These four adducts are expressed in an inducible but temporally biphasic manner in Jurkat T cells (20) . Specifically, within minutes after PMA activation of Jurkat cells, the p55 (NF-KB p50) and p75 (NF-KB p65) adducts are detectable in the nucleus (20) . In addition to p55 (NF-KB p50) and p75 (NF-KB p65), which form a heteromeric complex migrating in the B1 position, a second set of inducible KB-enhancer-binding proteins have been identified in T cells, namely p50 and p85 (c-ret) (20, 21 They concluded that NF-KB induction in U937 cells was dependent upon cellular differentiation and that the constitutive expression of NF-KB in THP-l cells reflected its more mature, or differentiated, phenotype. Our data certainly do not exclude a possible role for cellular differentiation in the regulation of NF-KB p50 and NF-KB p65. In fact, our findings of increased constitutive HIV-1 LTR CAT activity and low level B 1 complex formation in the relatively mature THP-1 cells support the idea that differentiation of monocytes may play a role in the expression of these proteins. However, the present demonstration ofthe constitutive nuclear expression ofthe proteins comprising the p50 and p55 crosslinked adducts in immature U937 cells both confirms and extends the earlier studies of Lubon et al. (53) and Collart et al. (54) and demonstrates that differentiation is not a prerequisite for NF-KB p50 expression in these monocytic cells. Furthermore, our finding that TNFa activation of U937 cells leads to the extremely rapid induction ofthe nuclear expression of NF-KB p50 and NF-KB p65 also demonstrates that differentiation ofthese immature U937 cells is not a prerequisite for the nuclear expression of NF-KB p50 or NF-KB p65. Finally, our finding that both NF-KB p50 and NF-KB p65 are markedly inducible in the more differentiated THP-1 cells suggests that cellular activation rather than cellular differentiation probably plays the dominant role in the regulated expression of these proteins in monocytic cells. In many respects these monocytic cells exhibit a phenotype of KB enhancerbinding protein expression intermediate between that of mature B cells and most T cells. In many mature B cell populations, both NF-KB p50 and NF-KB p65 are constitutively expressed whereas in most T cell lines examined neither of these NF-KB subunits are constitutively expressed in the nucleus.
The induction of p75 (NF-KB p65) and increased expression ofp55 (NF-KB p50) occurring after TNFa or PMA stimulation of these monocytic cells appears functionally important, as activity ofthe HIV-1 LTR is coordinately induced 5-10-fold in a KB enhancer-dependent manner in both U937 and THP-1 cells. These findings agree with the recent studies ofPomerantz et al. (55) , who have described activation ofthe HIV-I LTR by PMA + PHA, TNFa, or LPS in both U937 and THP-l cells.
These results are consistent with our recent studies demonstrating that NF-KB p65, but not NF-KB p50, contains a potent transcriptional activator domain (27) . Thus, as with T cells, the state of monocytic cell activation importantly determines KB enhancer-binding protein expression and significantly contributes to the overall state of HIV-1 gene expression. These findings suggest that cellular stimuli that induce the nuclear expression ofNF-KB p65 in monocytes in vivo may significantly contribute to the activation of HIV-I replication.
